R1 RCM Holdco Inc
F:6HL0

Watchlist Manager
R1 RCM Holdco Inc Logo
R1 RCM Holdco Inc
F:6HL0
Watchlist
Price: 13.4 EUR Market Closed
Market Cap: €5.6B

EV/GP

18.3
Current
6%
More Expensive
vs 3-y average of 17.2

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
18.3
=
Enterprise Value
€7.3B
/
Gross Profit
$472.7m

Enterprise Value to Gross Profit (EV/GP) ratio compares a company`s total enterprise value to its gross profit. It shows how much investors are paying for each dollar of the company`s gross profit, including both equity and debt.

EV/GP
18.3
=
Enterprise Value
€7.3B
/
Gross Profit
$472.7m

Valuation Scenarios

R1 RCM Holdco Inc is trading above its 3-year average

If EV/GP returns to its 3-Year Average (17.2), the stock would be worth €12.64 (6% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-72%
Maximum Upside
No Upside Scenarios
Average Downside
36%
Scenario EV/GP Value Implied Price Upside/Downside
Current Multiple 18.3 €13.4
0%
3-Year Average 17.2 €12.64
-6%
5-Year Average 18.2 €13.37
0%
Industry Average 5.2 €3.78
-72%
Country Average 6.5 €4.78
-64%

Forward EV/GP
Today’s price vs future gross profit

Not enough data available to calculate forward EV/GP

Peer Comparison

All Multiples
EV/GP
P/E
All Countries
Close
P/E Multiple
Earnings Growth PEG
US
R1 RCM Holdco Inc
F:6HL0
Average P/E: 22.1
Negative Multiple: -108.8
253%
N/A
US
CVS Health Corp
NYSE:CVS
59.9
90%
0.7
US
C
Cigna Group
XMUN:CGN
14.1
19%
0.7
US
Cigna Corp
NYSE:CI
12.9
19%
0.7
DE
Fresenius SE & Co KGaA
XETRA:FRE
18.4
25%
0.7
DE
Fresenius Medical Care AG
XMUN:FME
22.8
15%
1.5
US
Laboratory Corporation of America Holdings
NYSE:LH
24.1
27%
0.9
US
Quest Diagnostics Inc
NYSE:DGX
21.1
12%
1.8
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11
15%
0.7
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -27.3 N/A N/A
US
DaVita Inc
NYSE:DVA
14.2
19%
0.7

Market Distribution

Higher than 87% of companies in the United States of America
Percentile
87th
Based on 9 428 companies
87th percentile
18.3
Low
0 — 4.2
Typical Range
4.2 — 10.6
High
10.6 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 4.2
Median 6.5
70th Percentile 10.6
Max 1 764 211.7

R1 RCM Holdco Inc
Glance View

Market Cap
5.6B EUR
Industry
Health Care

R1 RCM Holdco Inc. is a leading provider of revenue cycle management (RCM) services to healthcare providers across the United States. Originating from the need for healthcare institutions to efficiently handle the intricacies of billing and collections, R1 RCM offers comprehensive solutions that streamline patient registration, medical coding, billing, and data analytics. By leveraging cutting-edge technology and automation, the company helps hospitals and healthcare systems optimize their operations, reduce administrative burdens, and enhance cash flow. This involves a meticulous approach to improving the accuracy of billing and collections processes, ultimately boosting revenue realization for its clients. The company generates revenue primarily through long-term contracts with healthcare facilities, where it earns fees based on the savings and additional cash collected on behalf of its clients. This results in a business model that is closely aligned with the financial performance of its partners, incentivizing efficiency and improved cash management. R1 RCM's services include managing clients' revenue streams from insurance payers, government programs, and patients, ensuring compliance with regulatory standards, and providing strategic insights through data analytics. This not only contributes to the company's growth but also positions it as a vital ally in the healthcare sector’s ongoing battle against rising operational costs.

6HL0 Intrinsic Value
9.45 EUR
Overvaluation 29%
Intrinsic Value
Price €13.4
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett